Home

KIF5

KIF5 refers to a family of conventional kinesin heavy chains in humans, comprising KIF5A, KIF5B, and KIF5C. These motor proteins form the core of kinesin-1 and drive microtubule-based transport toward the plus ends of microtubules, supporting cargo movement within the cytoplasm, neurons, and other cell types. Their activity underpins fast axonal transport, organelle distribution, and intracellular trafficking essential for cell function and development.

Structural features include an N-terminal motor domain that binds and hydrolyzes ATP to generate force, a coiled-coil

Expression patterns vary among paralogs: KIF5A is enriched in neurons and is particularly associated with neuronal

Clinical significance is observed when KIF5A harbors pathogenic variants, which have been linked to hereditary sensory

stalk
that
enables
dimerization,
and
a
C-terminal
tail
that
mediates
cargo
binding
through
associations
with
kinesin
light
chains
(KLC1-4)
and
various
adapter
proteins.
Cargo
specificity
is
achieved
through
interactions
with
adaptors
such
as
Milton/Miro
for
mitochondria
and
JIP
family
proteins
for
vesicular
cargo.
Regulation
occurs
via
autoinhibition
of
the
motor
that
is
relieved
upon
cargo
binding
or
post-translational
modifications,
allowing
controlled
activation
of
transport.
cargo
transport;
KIF5B
is
more
broadly
expressed;
KIF5C
is
preferentially
found
in
the
brain.
Together,
KIF5
proteins
participate
in
transporting
mitochondria,
synaptic
vesicle
precursors,
receptors,
and
other
organelles,
contributing
to
neuronal
development,
maintenance,
and
overall
cellular
organization.
and
autonomic
neuropathy
type
I
(HSAN
I)
and
spinocerebellar
involvement
such
as
SPG10;
other
KIF5A
variants
have
been
reported
in
various
neurodevelopmental
and
neurodegenerative
contexts.
Disruption
of
KIF5-mediated
transport
is
implicated
in
diseases
characterized
by
impaired
axonal
transport
and
neuronal
integrity.